Technical Analysis for GBIM - Globeimmune Cm

Grade Last Price % Change Price Change
grade B 0.32 6.45% 0.0194
GBIM closed up 6.45 percent on Monday, August 10, 2020, on 6 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical GBIM trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Wide Bands Range Expansion 0.00%
Fell Below 20 DMA Bearish 6.45%
Narrow Range Bar Range Contraction 6.45%
BB Squeeze Ended Range Expansion 6.45%
Wide Bands Range Expansion 6.45%
Below Lower BB Weakness 6.45%
Gapped Down Weakness 6.45%
Crossed Above 20 DMA Bullish -25.58%
Hammer Candlestick Bullish -25.58%
Older signals for GBIM ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


GlobeImmune, Inc. is a biopharmaceutical company. The Company is focused on developing products for the treatment of cancer and infectious diseases based on its Tarmogen platform. The Company's segment is the business of developing and commercializing various biopharmaceutical products. The Company's infectious disease product candidates include GS-4774, which is in Phase II for the treatment of chronic hepatitis B infection; GI-19000; GI-2010, which is in the preclinical stage of development for the treatment of Human immunodeficiency virus (HIV), and GI-18000, which is in the preclinical stage of development for the treatment of Chronic hepatitis D infection. The Company's oncology product candidates include GI-6207, which is in Phase II for the treatment of medullary thyroid cancer; GI-6301, and GI-4000, which is in Phase IIb for the treatment of Resected pancreas cancer, and in Phase II for the treatment of Non-small cell lung cancer and colorectal cancer.
Medicine Medical Specialties RTT Cancer Biopharmaceutical Infectious Diseases Treatment Of Cancer Colorectal Cancer Hiv Infectious Causes Of Cancer Hepatitis Biopharmaceutical Products Infectious Disease Non Small Cell Lung Cancer Treatment Of Non Small Cell Lung Cancer

Is GBIM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News


Indicator Value
52 Week High 0.485
52 Week Low 0.0351
Average Volume 29,651
200-Day Moving Average 0.1293
50-Day Moving Average 0.2404
20-Day Moving Average 0.4024
10-Day Moving Average 0.3916
Average True Range 0.0712
ADX 36.38
+DI 34.2459
-DI 19.7553
Chandelier Exit (Long, 3 ATRs ) 0.2714
Chandelier Exit (Short, 3 ATRs ) 0.5137
Upper Bollinger Band 0.4889
Lower Bollinger Band 0.3159
Percent B (%b) 0.02
BandWidth 42.9920
MACD Line 0.0289
MACD Signal Line 0.0511
MACD Histogram -0.0221
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.5150
Resistance 3 (R3) 0.5367 0.4933 0.4825
Resistance 2 (R2) 0.4933 0.4437 0.4825 0.4717
Resistance 1 (R1) 0.4067 0.4130 0.3850 0.3850 0.4608
Pivot Point 0.3633 0.3633 0.3525 0.3525 0.3633
Support 1 (S1) 0.2767 0.3137 0.2550 0.2550 0.1792
Support 2 (S2) 0.2333 0.2830 0.2225 0.1683
Support 3 (S3) 0.1467 0.2333 0.1575
Support 4 (S4) 0.1250